Pharmacogenomics of neurodegenerative diseases
- 9 February 2001
- journal article
- review article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 413 (1) , 11-29
- https://doi.org/10.1016/s0014-2999(00)00939-0
Abstract
No abstract availableKeywords
This publication has 170 references indexed in Scilit:
- Tau gene polymorphisms and apolipoprotein E ε4 may interact to increase risk for Alzheimer’s diseaseNeuroscience Letters, 1999
- Association of the Estrogen Receptor α Gene Polymorphisms with Sporadic Alzheimer's DiseaseBiochemical and Biophysical Research Communications, 1999
- A polymorphism in the regulatory region of APOE associated with risk for Alzheimer's dementiaNature Genetics, 1998
- Upregulation of the Anti-apoptotic Protein Bcl-2 May Be an Early Event in Neurodegeneration: Studies on Parkinson's and Incidental Lewy Body DiseaseBiochemical and Biophysical Research Communications, 1997
- Cryptic physiological trophic support of motoneurons by LIF revealed by double gene targeting of CNTF and LIFCurrent Biology, 1996
- Mechanisms of Neuronal Degeneration in Alzheimer's DiseaseNeuron, 1996
- Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's diseaseThe Lancet, 1996
- Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiationAnnals of Neurology, 1994
- Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosisCell, 1993
- Stable transfection of calbindin-D28k into the GH3 cell line alters calcium currents and intracellular calcium homeostasisNeuron, 1992